The Limited Times

Now you can see non-English news...

John Hackett (Abbott): "It will be necessary to detect future pandemics more quickly"


INTERVIEW - The head of R&D at Abbott Diagnostic calls for breaking down the barriers between all health players.

John Hackett is responsible for R&D for Abbott's diagnostics business.

The American company, which also designs medical devices (glucose sensors, pacemakers, defibrillators, etc.), is at the heart of the health crisis with its range of Covid tests.

He looks back on the challenges of the sector and on the place taken by the diagnosis thanks to the pandemic.

Read also

Covid-19: towards a more serene end of the year

Le FIGARO.- How has the pandemic transformed our approach to diagnosis?



Before the Covid, we had never talked so much about tests and diagnostics!

However, 70% of medical decisions are made on the basis of diagnostic elements (blood tests, samples, etc.).

Today, the patient's journey must be conceived in its entirety, from prevention to therapy.

Diagnosis has a key role to play in saving lives and reducing health care costs.

It will be an increasingly digital sector, where algorithms will help define profiles of patients at risk, with more apps and connected tools.

This article is for subscribers only.

You have 84% left to discover.

To cultivate your freedom is to cultivate your curiosity.

Continue reading your article for € 1 the first month


Already subscribed?

Log in

Source: lefigaro

All business articles on 2021-10-15

You may like

Tech/Game 2021-09-14T08:13:14.613Z
News/Politics 2021-09-14T07:10:18.640Z
News/Politics 2021-10-29T04:44:14.273Z

Trends 24h

Business 2021-11-10T12:55:54.512Z


© Communities 2019 - Privacy